Literature DB >> 7697973

Acute myelogenous leukemia in a rheumatoid arthritis patient under cyclosporine A therapy.

P Casoli, B Tumiati.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7697973     DOI: 10.1007/bf02243012

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  15 in total

1.  The changing pattern of posttransplant malignancies.

Authors:  I Penn
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

Review 2.  Cancer in autoimmune diseases.

Authors:  O Sela; Y Shoenfeld
Journal:  Semin Arthritis Rheum       Date:  1988-11       Impact factor: 5.532

Review 3.  The risk of neoplasms in patients treated with cyclosporine A.

Authors:  I T Cockburn; P Krupp
Journal:  J Autoimmun       Date:  1989-10       Impact factor: 7.094

4.  Experimental models of malignancies after cyclosporine therapy.

Authors:  H Shinozuka; A Hattori; T J Gill; H W Kunz
Journal:  Transplant Proc       Date:  1988-06       Impact factor: 1.066

5.  Cytogenetic findings in acute monocytic leukemia in a renal allograft recipient.

Authors:  G M Pikler; B Say; S Stamper
Journal:  Cancer Genet Cytogenet       Date:  1986-02-01

Review 6.  Immunosuppressive drugs and corticosteroids in the treatment of rheumatoid arthritis.

Authors:  M Arnold; L Schrieber; P Brooks
Journal:  Drugs       Date:  1988-09       Impact factor: 9.546

7.  Cancer mortality in patients with rheumatoid arthritis.

Authors:  M Laakso; O Mutru; H Isomäki; K Koota
Journal:  J Rheumatol       Date:  1986-06       Impact factor: 4.666

Review 8.  Tumors of the immunocompromised patient.

Authors:  I Penn
Journal:  Annu Rev Med       Date:  1988       Impact factor: 13.739

9.  Malignancies in rheumatoid arthritis patients treated with cyclosporin A.

Authors:  F Arellano; P Krupp
Journal:  Br J Rheumatol       Date:  1993-03

Review 10.  Malignancy in autoimmune diseases.

Authors:  L J Kinlen
Journal:  J Autoimmun       Date:  1992-04       Impact factor: 7.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.